We are driven by the passion to nurture and preserve the precious moments of everyday life for all people, regardless of their health condition. From treatment to disease prevention, we will continue to develop innovative new drugs that contribute to better health and bring smiles to the faces of people everywhere.
April 01, 2024
News Releases
Corporate Venture Capital Firm Taiho Ventures Selected for AMED's Strengthening Program for Pharmaceutical Startup Ecosystem (PDF:239.7 KB)
March 13, 2024
News Releases
Taiho Pharmaceutical Launches Solmack® Q-Arl D, Chewable Tablets for Diarrhea Caused by Overeating and Overdrinking that Can Be Taken Anywhere Without Water - A New Addition to the Solmack Product Line
March 01, 2024
News Releases
Taiho Pharma Enters Exclusive License Agreement with Haihe Biopharma for Gumarontinib (SCC244), an Agent for Non-Small Cell Lung Cancer(PDF:354.6 KB)
February 07, 2024
News Releases
Otsuka Group Selected for CDP Climate Change A List for a Second Consecutive Year(PDF:556.1 KB)
January 18, 2024
News Releases
Taiho Pharmaceutical Reduces Employee Smoking Rate to 0.3%
February 14, 2024
Information
Otsuka Holdings announces FY2023 financial results
January 09, 2024
Information
Donations to Support Relief Efforts Following the Noto Peninsula Earthquake
February 22, 2023
Information
Donations to Support Relief Efforts Following Earthquakes in Turkey and Syria
March 17, 2022
Information
■Otsuka Holdings Donations for Humanitarian Support to Ukrainian People
July 12, 2018
Information
Announcement of Support from Otsuka Holdings and Its Group Companies in the Aftermath of Severe Storms in Japan(PDF:165.9 KB)
MOVIE
Introducing Taiho Pharmaceutical’s history and its unique approaches in R&D.
This video is not intended to constitute promotion or advertisement of any products.